Table 7.
Average cost saving for 1.7% HbA1c reduction
| Complications | Average cost per patient (USD) | Average reduction for 1.7% HbA1c improvement (%) | Average Cost saving (USD) |
|---|---|---|---|
| Microvascular |
61.98 |
62.9 |
38.98 |
| Cardiovascular disease |
106.20 |
23.8 |
25.28 |
| Peripheral vascular disease |
20.53 |
73.1 |
15.00 |
| Ophthalmic |
35.00 |
32.3 |
11.31 |
| Disability and mortality |
216.20 |
29.75 |
64.32 |
| Total | 439.9 | 154.89 |
USD; USA Dollars.